Annie-claude Benichou

Biography

Dr. Benichou has more than 23 years of experience in the management of clinical development of drugs and high-tech medical devices in Europe and in the USA. After she earned a medical degree from the University of Toulouse in France, she obtained inter-university degrees in methodology for clinical development, in pharmacovigilance, and in pharmaco-epidemiology. In 2004, she joined the Stragen Group for the clinical development of an orphan drug in onco-hematology (FDA approved in 2012) as well as for project coordination with the European Medicines Agency, and endorsed the Global Qualified Person for Pharmacovigilance role and responsibilities since 2007. She is now managing a sister company within the Stragen Group, dedicated to services in clinical development strategy and pharmacovigilance. She has the CMO position within Alaxia’s development team since January 2011.

Research Interest

Pharmaceutical Sciences